Mark Pegram, MD, Discusses Major Takeaways From the IDEAL Trial in HR+ Breast Cancer Cancer Network, 29 Jul 2022 Mark Pegram, MD, spoke the most important data from the IDEAL trial he believes his colleagues should take away.